喘息空间：氧气配给对新冠病毒感染健康结局的影响
Room to Breathe: The Impact of Oxygen Rationing on Health Outcomes in SARS-CoV2.
作者信息
Goyal Daniel K, Mansab Fatma, Bhatti Sohail
机构信息
COVID-19 Research Group, Public Health Gibraltar, Gibraltar Health Authority, Gibraltar, United Kingdom.
Department of Medicine, Acute General Medicine, St. Bernard's Hospital, Gibraltar, United Kingdom.
出版信息
Front Med (Lausanne). 2021 Jan 6;7:573037. doi: 10.3389/fmed.2020.573037. eCollection 2020.
Abstract
As the primary surge of coronavirus disease 2019 (COVID-19) wanes in many countries, it is important to reconsider best practice. More cases, probably the majority of cases, are yet to come. Hopefully, during this next phase, we will have more time, more resources, and more experience from which to affect better outcomes. Here, we examine the compromised oxygen strategy that many nations followed. We explore the evidence related to such strategies and discuss the potential mortality impact of delaying oxygen treatment in COVID-19 pneumonia.
摘要
随着2019冠状病毒病（COVID-19）的第一波疫情在许多国家逐渐消退，重新审视最佳实践非常重要。更多病例，可能是大多数病例，尚未出现。希望在下一阶段，我们将有更多时间、更多资源以及更多经验，从而实现更好的治疗效果。在此，我们审视了许多国家遵循的保守氧疗策略。我们探究与这些策略相关的证据，并讨论在COVID-19肺炎中延迟氧疗对死亡率的潜在影响。
相似文献
1
Room to Breathe: The Impact of Oxygen Rationing on Health Outcomes in SARS-CoV2.
Front Med (Lausanne). 2021 Jan 6;7:573037. doi: 10.3389/fmed.2020.573037. eCollection 2020.
2
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Trials. 2020 Jun 3;21(1):472. doi: 10.1186/s13063-020-04400-4.
3
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
4
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
5
Oxygen and Mortality in COVID-19 Pneumonia: A Comparative Analysis of Supplemental Oxygen Policies and Health Outcomes Across 26 Countries.
Front Public Health. 2021 Jul 13;9:580585. doi: 10.3389/fpubh.2021.580585. eCollection 2021.
6
Pathogenesis-directed therapy of 2019 novel coronavirus disease.
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
7
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
8
Guidelines for Balancing Priorities in Structural Heart Disease During the COVID-19 Pandemic.
Cardiovasc Revasc Med. 2020 Aug;21(8):1030-1033. doi: 10.1016/j.carrev.2020.05.040. Epub 2020 May 30.
9
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.
J Med Virol. 2020 Jun;92(6):552-555. doi: 10.1002/jmv.25728. Epub 2020 Mar 11.
10
Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
Trials. 2020 Sep 16;21(1):794. doi: 10.1186/s13063-020-04633-3.
引用本文的文献
1
Oxygen: Friend or foe in the COVID-19 battle.
Clin Case Rep. 2021 Dec 26;9(12):e05254. doi: 10.1002/ccr3.5254. eCollection 2021 Dec.
2
Oxygen and Mortality in COVID-19 Pneumonia: A Comparative Analysis of Supplemental Oxygen Policies and Health Outcomes Across 26 Countries.
Front Public Health. 2021 Jul 13;9:580585. doi: 10.3389/fpubh.2021.580585. eCollection 2021.
本文引用的文献
1
Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters.
Environ Res. 2020 Sep;188:109890. doi: 10.1016/j.envres.2020.109890. Epub 2020 Jul 1.
2
Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting?
BMC Med. 2020 Aug 19;18(1):260. doi: 10.1186/s12916-020-01735-2.
3
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.
Lancet Infect Dis. 2020 Oct;20(10):1135-1140. doi: 10.1016/S1473-3099(20)30434-5. Epub 2020 Jun 8.
4
Silent hypoxia: A harbinger of clinical deterioration in patients with COVID-19.
Am J Emerg Med. 2020 Oct;38(10):2243.e5-2243.e6. doi: 10.1016/j.ajem.2020.05.044. Epub 2020 May 22.
5
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
6
[Statement of the Austrian Society of Pneumology (ASP)].
Wien Klin Mag. 2020;23(3):92-115. doi: 10.1007/s00740-020-00350-4. Epub 2020 May 18.
7
Initial diagnosis and management of adult community-acquired pneumonia: a 5-day prospective study in Shanghai.
J Thorac Dis. 2020 Apr;12(4):1417-1426. doi: 10.21037/jtd.2020.03.02.
8
Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction.
Histopathology. 2020 Aug;77(2):198-209. doi: 10.1111/his.14134. Epub 2020 Jul 5.
9
Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis.
J Clin Virol. 2020 Jun;127:104371. doi: 10.1016/j.jcv.2020.104371. Epub 2020 Apr 14.
10
Variable computed tomography appearances of COVID-19.
Singapore Med J. 2020 Jul;61(7):387-391. doi: 10.11622/smedj.2020066. Epub 2020 Apr 21.
Zotero 插件